KDR and neoplasm: EGCG combined with silibinin synergistically facilitated the downregulation of proangiogenic VEGF, VEGFR2, and miR-17-92 family and the upregulation of anti-angiogenic miR-19b, when ECs were cocultured with tumor cells (146).